Event Overview:

The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 15th year, is a unique and exciting multidisciplinary program. The Congress is the premiere global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease (CVD), and energy balance, linking basic research to clinical practice, and highlighting our theme: Exploring New Frontiers in Metabolism - Tomorrow’s Clinical Science Today.

For more than a decade, the WCIRDC has brought researchers, physicians and healthcare professionals together for a distinctive international program that bridges the latest developments from the bench to bedside. “I heard it first at the Congress” is a frequent remark from the audience over the years, many of whom attend year after year. Researchers present their latest data on everything from biomarkers to new physiologic insights to new ideas for therapies. WCIRDC offers attendees a unique experience to interact with the distinguished global faculty for a collaborative experience that explores the newest understanding of metabolic diseases and the development of future therapeutic modalities.

Since Dr. Gerald Reaven’s pioneering work crystallized the relationship between insulin resistance (IR), diabetes, and CVD, the Congress’ focus has expanded to the fat cell, lipids, the kidney, the brain, bone, energy metabolism, inflammation, CVD complications and cancer.  The Congress addresses atherosclerosis, hypertension, and hypercoagulation as well as pharmaceutical interventions like incretins, SGLT2i’s and PCSK9i’s to name a few. The goal is to understand the state of the art pathophysiology and to develop appropriate comprehensive clinical management strategies.

For primary care clinicians, the Congress will feature a series of workshops and “meet the expert” panels addressing the clinical management of kidney disease, diabetes, obesity, lipids, the high risk CVD patients and more. To make basic and clinical research topics relevant to clinical medicine, there will be commentaries on its clinical implications by recognized clinical experts. The Congress’ intimate setting promotes a lot of personal contact between participants and the faculty wherein everyone learns from the free flow of questions and personal observations.

Target Audience
This educational initiative is designed for cardiologists, endocrinologists, gastroenterologists, oncologists, internists, diabetologists, OBGYNs, pediatricians, dieticians, nurse practitioners, pharmacists, and any other health care professionals who are interested in insulin resistance, diabetes, obesity, cardiovascular disease, and multiple metabolic mechanisms’ effects on health and society, as well as on potential treatment and prevention.

Exhibitor Information:

We offer Exhibit space to expand your company’s appreciation, and to expose your products and services to the nearly 500 health care professionals who attend the annual meeting.

WCIRDC is committed to give exhibitors the best value for their participation.

The WCIRDC is an excellent opportunity to meet with globally-recognized medical leaders, clinicians and scientists who present and share their knowledge. The WCIRDC is designed to evaluate both clinical and basic science aspects of insulin resistance, obesity, diabetes, and CVD.

The WCIRDC achieves a great balance between clinical practice and research, by utilizing a state of the art approach: “Exploring New Frontiers in Metabolism - Tomorrow’s Clinical Science Today!”

The WCIRDC will dedicate an area, separate from the educational program, where your company will be able to exhibit products, equipment and services.

About MEEF:

The Metabolic Endocrine Education Foundation, (MEEF), is a leading national health foundation devoted to improving patients and public health through education. MEEF, a nonprofit organization (USA- 501 ©3), sponsors research educational activities for professional health providers, patients and the community at large.